A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis
Clinical trial NCT06808815 · COMPLETED
Trial details
- NCT number
- NCT06808815
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2022-08-23
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.